Trevena
TRVN
#10608
Rank
โ‚ฌ0 M
Marketcap
0,01022ย โ‚ฌ
Share price
0.00%
Change (1 day)
-99.32%
Change (1 year)

Market capitalization of Trevena (TRVN)

Market cap: โ‚ฌ0 Million

As of December 2025 Trevena has a market cap of โ‚ฌ0 Million. This makes Trevena the world's 10608th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Trevena from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0 M-99.42%
2024โ‚ฌ1.52 M-84.59%
2023โ‚ฌ9.91 M6.99%
2022โ‚ฌ9.26 M-89.05%
2021โ‚ฌ84.61 M-69.6%
2020โ‚ฌ0.27 B293.62%
2019โ‚ฌ70.72 M128.55%
2018โ‚ฌ30.94 M-62.75%
2017โ‚ฌ83.07 M-71.6%
2016โ‚ฌ0.29 B-40.03%
2015โ‚ฌ0.48 B152.85%
2014โ‚ฌ0.19 B

End of Day market cap according to different sources

On Dec 11th, 2025 the market cap of Trevena was reported to be:

N/A
by Nasdaq info icon info icon
โ‚ฌ0 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚ฌ145.52 B 1,648,846,932.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚ฌ6.32 B 71,683,832.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
โ‚ฌ6.9 M 78,149.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ210.58 B 2,385,967,439.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚ฌ5.24 B 59,482,034.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
โ‚ฌ12.41 M 140,555.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚ฌ0.39 B 4,427,600.61%๐Ÿ‡บ๐Ÿ‡ธ USA